Literature DB >> 27982138

Velocardiofacial Syndrome-Associated Psychiatric Illness and Response to Aripiprazole: A Case Study.

Richard R Brewington1, Jessica A Hellings1, Merlin G Butler1.   

Abstract

Entities:  

Year:  2008        PMID： 27982138      PMCID： PMC5151172     

Source DB:  PubMed          Journal:  Am J Psychiatry Resid J        ISSN： 2474-4662


× No keyword cloud information.
  3 in total

1.  Clozapine treatment of psychosis associated with velo-cardio-facial syndrome: benefits and risks.

Authors:  S Gladston; D J Clarke
Journal:  J Intellect Disabil Res       Date:  2005-07

2.  Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Carl Feinstein; Tracy Thompson; Eugene Gu; Lauren Penniman; Ellen Van Stone; Hower Kwon; Stephan Eliez; Allan L Reiss
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

3.  Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk.

Authors:  Carl Feinstein; Stephan Eliez; Christine Blasey; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.